PVLA
Palvella Therapeutics
PVLA
PVLA
75 hedge funds and large institutions have $165M invested in Palvella Therapeutics in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.07% more ownership
Funds ownership: 0.53% → 0.6% (+0.07%)
15% less call options, than puts
Call options by funds: $1.59M | Put options by funds: $1.88M
Holders
75
Holding in Top 10
–
Calls
$1.59M
Puts
$1.88M
Top Buyers
| 1 | +$7.76M | |
| 2 | +$6.04M | |
| 3 | +$5.76M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$4.51M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.83M |
Top Sellers
| 1 | -$4.68M | |
| 2 | -$3.83M | |
| 3 | -$2.64M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$982K |
| 5 |
E
Ergoteles
New York
|
-$796K |